CALL US: (352) 265-0725
James Lynch, M.D.

James W Lynch, M.D. - Research & Publications

(352) 265-0725

Request an Appointment

Publications

  • Lynch JW. A Piece of My Mind: Regaining Compassion, JAMA, May 13, 1998, 279(18):1422
  • Lucio Gordan, William B. Grow, Raul C. Braylan, Nancy P. Mendenhall, Vonda Douglas, Annette Pusateri, Lakshmi Balasubramanian, James W. Lynch. Phase II Trial of Individualized Pharmacokinetic Dosing of Rituximab Maintenance for Patients with CD-20 Positive Lymphoproliferative Disorders. J Clin Oncol. 2005 Feb 20;23(6):1096-102
  • Walsh K, Lynch JW, Al-Quran S, Li Y and Braylan R. Discordant Expression of CD20 by Flow Cytometry and Immunohistochemistry in a Patient Responding to Rituximab: An Unusual Mechanism. Clin Lymphoma Myeloma. 2007 Jan;7(4):319-22.
  • Chera B, Olivier K, Morris C, Lynch J, Mendenhall M. Clinical Presentation and Outcomes of Lymphocyte-predominant Hodgkin's Disease at the University of Florida: Am J Clin Oncol. 2007 Dec; 30(6):601-6.
  • Advancing Educators and Education: Defining the Components and Evidence of Educational Scholarship. AAMC Group on Educational Affairs Consensus Conference on Educational Scholarship. 2007
  • Daniel T. Chang, MD; Nancy P. Mendenhall, MD; James W. Lynch, MD; Christopher G. Morris, MS; Kenneth R. Olivier, MD. Long-term outcomes for stage I-II aggressive non-Hodgkin's lymphoma of Waldeyer's ring: Am J Clin Oncol. 2009 Jun;32(3):233-7
  • James W Lynch MD; Information Overload and the Need for Wisdom: A Medical Perspective: Reconsiderations Vol 9 No 1. December 2009
  • Effective Dose Reduction to Cardiac Structures Using Protons Compared with 3DCRT and IMRT in Mediastinal Hodgkin Lymphoma.Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP.Int J Radiat Oncol Biol Phys. 2012 Mar 2. [Epub ahead of print].
  • Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.
  • Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy.Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K.Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1122-7.

Research Interests

  • Medical Education
  • Experimental therapeutics and prognostic factors for Hodgkin's and Non-Hodgkin's Lymphoma